GranBio is a Brazilian biotech company that creates solutions to transform biomass into renewable products such as biofuels, biochemicals, nano materials and nutrients. With its innovative business model, the company is the only one in the sector to be active from start to finish in the chain of production – from raw material to distribution of the final product – integrating its own and third-party technologies.
Created in June of 2011 by Bernardo Gradin, GranBio operates the Southern Hemisphere’s first commercial-scale plant for second-generation (2G) ethanol, an unprecedented project in Brazilian industry. The factory – called Bioflex 1 – has been operational since September of 2014, in Alagoas. The production of biofuel from sugarcane straw and bagasse, the raw material that until then had been discarded or burned in the field, places the company among the planet’s most sustainable, in its sector.
Chosen in 2013 as one of the most innovative companies in South America by the American magazine Fast Company, GranBio has a Synthetic Biology Research Center and an Experimental Station to develop new sources of biomass. Since 2013, it has also had a stake in the American clean technology company, American Process Inc., or API.
In the area of biochemicals, it is partnered with Rhodia – a company in the Solvay Group – in a globally pioneering project to produce bio n-butanol, which is used in making paints and solvents.
GranBio is controlled by GranInvestimentos S.A., a holding company of the Gradin family, and has BNDESPar, the Brazilian Development Bank’s investment arm, as a minority stakeholder, with 15% of the total capital stock.